TMA Provides Resources about Ebola for Physicians and Healthcare Workers

April 11, 2014 Sara Bergmanson

In response to the recent diagnosis of Ebola in a Dallas man, Texas Medical Association has provided a list of information and resources about the disease for the Texas healthcare community.

Below is a compilation of links to the resources provided by TMA:

CDC health advisory for evaluating patients for Ebola
TMA “What is Ebola?” hand out for your patients
Dallas County Health and Human Services guidance on Ebola
Dallas County Health and Human Services diagnostic algorithm - helps to assist with testing and monitoring of patients with suspected Ebola virus disease
CDC Ebola information for health care workers
CDC Infection Prevention and Control Recommendations – for hospitalized patients with known or suspected Ebola Virus Disease in U.S. hospitals
CDC Checklist for Patients Being Evaluated for Ebola in the U.S
CDC Questions and Answers on Ebola
CDC: What is Contact Tracing?
CDC (via NPR): How Contagious is Ebola?
Ebola Preparedness for the U.S Healthcare System – webinar on demand
New England Journal of Medicine’s Ebola Outbreak page
Open letter to Texans from Dr. David Lakey, State Health Commissioner

To see the full blog post by TMA, please click here.

FDA Recommends Health Care Providers Stop Using Expression by Enhancement Medical LLC as a Dermal Filler

FDA recommends that health care providers stop using Expression by Enhancement Medical LLC as a subcutaneou...

AHA and ACCME Provide Ebola Education Package for Healthcare Providers and Institutions

The Ebola education package contains information about the safe management of patients with the disease in ...

TMA Provides Resources about Ebola for Physicians and Healthcare Workers

Previous Article

Next Article

TMA Provides Resources about Ebola for Physicians and Healthcare Workers

Previous Article

Next Article

Most Recent Articles

TMLT policyholders will receive a 10 percent dividend when they renew their policies in 2019.

Millennials are now the largest segment of our population, and they bring a different set of expectations and needs to health care than previous generations.

According to the FBI, human trafficking is the third-largest criminal activity in the world. (1) A form of human slavery, human trafficking is an estimated $32 billion a year industry.

Texas Governor issues proclamation marking the 15th anniversary of Texas medical liability reforms

Texas physicians will be required to use new schedule II prescription forms beginning January 1, 2019.

Improper disposal of electronic devices and media puts the information stored on those devices at risk for a breach. And when devices contain protected health information (PHI), it puts your patient’s

Dr. Milman co-teaches TMLT’s summer CME seminar series in Katy and McAllen in August, 2018.

MD Anderson Cancer Center was recently fined for HIPAA violations. Let's go behind the headlines and take a look at the case.

Recent events and reports offer a reminder that effective suicide prevention resources are available to the public and to health care providers for sharing with their patients.

The FDA has approved new labeling for the Orbera and ReShape balloon systems.

Allergan recalls sample packs of Taytulla birth control pills

For this year’s spring CME seminars, attorney Brett B. Rowe presented “How to Fight the Opioid Epidemic” in Austin and Houston. Here’s a brief recap with five risk management takeaways for physicians.

The financial impact of a data breach can be much greater than expected.

Criminals posing as U.S. Drug Enforcement Administration (DEA) agents are phoning physicians and requesting payment for false fines.

Texas physicians will soon be required to check the Texas Prescription Monitoring database before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.

A panel of experts will discuss how to manage risks related to protected health information. The webinar is presented by Cyber Trust Alliance and features TMLT’s cyber expert John Southrey.

The Food and Drug Administration (FDA) has initiated an investigation into the health risk of brain deposits following repeated use of gadolinium-based contrast units (GBCAs) for MRI